Market Currents
Abbott (ABT -0.4%) says its humanised monoclonal antibody for the treatment of glioma has been...
-
Wednesday, September 26, 2012, 11:37 AM ETAbbott (ABT -0.4%) says its humanised monoclonal antibody for the treatment of glioma has been granted orphan designation by the European Commission. Glioma affects approximately 1 in 10K people in the European Union, or the equivalent of a total of around 51K people.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
